Multiple Sclerosis And Related Disorders SCIE

國際簡稱：MULT SCLER RELAT DIS 參考譯名：多發(fā)性硬化癥及相關(guān)疾病

主要研究方向：CLINICAL NEUROLOGY 非預(yù)警期刊審稿周期：

《多發(fā)性硬化癥及相關(guān)疾病》(Multiple Sclerosis And Related Disorders)是一本由Elsevier出版的以CLINICAL NEUROLOGY為研究特色的國際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評論文章和綜述文章，及時報道該領(lǐng)域相關(guān)理論、實踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn)，旨在促進該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本未開放期刊，近三年沒有被列入預(yù)警名單。

3區(qū) 中科院分區(qū)
Q2 JCR分區(qū)
474 年發(fā)文量
2.9 IF影響因子
未開放 是否OA
25 H-index
2012 創(chuàng)刊年份
6 issues/year 出版周期
English 出版語言

Multiple Sclerosis is an area of ever expanding research and escalating publications. Multiple Sclerosis and Related Disorders is a wide ranging international journal supported by key researchers from all neuroscience domains that focus on MS and associated disease of the central nervous system. The primary aim of this new journal is the rapid publication of high quality original research in the field. Important secondary aims will be timely updates and editorials on important scientific and clinical care advances, controversies in the field, and invited opinion articles from current thought leaders on topical issues. One section of the journal will focus on teaching, written to enhance the practice of community and academic neurologists involved in the care of MS patients. Summaries of key articles written for a lay audience will be provided as an on-line resource.

A team of four chief editors is supported by leading section editors who will commission and appraise original and review articles concerning: clinical neurology, neuroimaging, neuropathology, neuroepidemiology, therapeutics, genetics / transcriptomics, experimental models, neuroimmunology, biomarkers, neuropsychology, neurorehabilitation, measurement scales, teaching, neuroethics and lay communication.

[ 查看全部 ]

投稿咨詢加急咨詢

Multiple Sclerosis And Related Disorders期刊信息

ISSN：2211-0348
出版語言：English
是否OA：未開放
E-ISSN：2211-0356
出版地區(qū)：ENGLAND
是否預(yù)警：否
出版商：Elsevier
出版周期：6 issues/year
創(chuàng)刊時間：2012
開源占比：0.135
Gold OA文章占比：19.66%
OA被引用占比：0.0983...
出版國人文章占比：0.05
出版撤稿占比：0.0019...
研究類文章占比：86.71%

Multiple Sclerosis And Related Disorders CiteScore評價數(shù)據(jù)（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數(shù)

5.8

0.99

0.8

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Neurology (clinical)	Q2	121 / 400	69%
大類：Medicine 小類：Neurology	Q2	59 / 192	69%

名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個指標(biāo)。當(dāng)年CiteScore 的計算依據(jù)是期刊最近4年（含計算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻數(shù)。例如，2022年的 CiteScore 計算方法為：2022年的 CiteScore =2019-2022年收到的對2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻數(shù)量注：文獻類型包括：文章、評論、會議論文、書籍章節(jié)和數(shù)據(jù)論文。

Multiple Sclerosis And Related Disorders中科院評價數(shù)據(jù)

中科院 2023年12月升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	CLINICAL NEUROLOGY 臨床神經(jīng)病學(xué)	4區(qū)

中科院 2022年12月升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	CLINICAL NEUROLOGY 臨床神經(jīng)病學(xué)	4區(qū)

中科院 2021年12月舊的升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	CLINICAL NEUROLOGY 臨床神經(jīng)病學(xué)	4區(qū)

中科院 2021年12月基礎(chǔ)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	CLINICAL NEUROLOGY 臨床神經(jīng)病學(xué)	3區(qū)

中科院 2021年12月升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	CLINICAL NEUROLOGY 臨床神經(jīng)病學(xué)	4區(qū)

中科院 2020年12月舊的升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	4區(qū)	CLINICAL NEUROLOGY 臨床神經(jīng)病學(xué)	4區(qū)

Multiple Sclerosis And Related Disorders JCR評價數(shù)據(jù)（2023-2024年最新版）

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：CLINICAL NEUROLOGY	SCIE	Q2	99 / 277	64.4%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：CLINICAL NEUROLOGY	SCIE	Q2	82 / 278	70.68%

Multiple Sclerosis And Related Disorders歷年數(shù)據(jù)統(tǒng)計

影響因子

中科院分區(qū)

Multiple Sclerosis And Related Disorders中國學(xué)者發(fā)文選摘

1、Safety of inactivated COVID-19 vaccines in autoimmune encephalitis: A real-world cross-sectional survey
Author: Liu, Xu; Guo, Kundian; Lu, Lu; Luo, Rong; Liu, Jie; Zhou, Dong; Hong, Zhen

Journal: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2023; Vol. 70, Issue , pp. -. DOI: 10.1016/j.msard.2022.104495
2、Significant retinal microvascular impairments in multiple sclerosis assessed through optical coherence tomography angiography
Author: Wang, Xuejiao; Wang, Xuqian; Chou, Yuyu; Ma, Jin; Zhong, Yong

Journal: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2023; Vol. 70, Issue , pp. -. DOI: 10.1016/j.msard.2023.104505
3、Secreted aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) is a promising predictor for the severity of acute AQP4-IgG positive neuromyelitis optica spectrum disorder
Author: Yuan, Congcong; Liu, Xueyu; Cai, Shuang; Zhang, Lu; Guo, Ruoyi; Jia, Zhen; Sun, Yafei; Li, Bin

Journal: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2023; Vol. 70, Issue , pp. -. DOI: 10.1016/j.msard.2023.104504
4、Differentiation of MOGAD in ADEM-like presentation children based on FLAIR MRI features
Author: Wei, Shaonong; Xu, Lu; Zhou, Deyang; Wang, Tianlei; Liu, Kezhou; Gao, Feng; Cao, Jiuwen

Journal: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2023; Vol. 70, Issue , pp. -. DOI: 10.1016/j.msard.2022.104496
5、Efficacy and safety of repeated low-dose rituximab therapy in relapsing-remitting multiple sclerosis: A retrospective case series study
Author: Zhao, Daidi; Zhao, Cong; Lu, Jiarui; Han, Yu; Sun, Tangna; Ren, Kaixi; Ma, Chao; Zhang, Chao; Li, Hongzeng; Guo, Jun

Journal: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2023; Vol. 70, Issue , pp. -. DOI: 10.1016/j.msard.2023.104518
6、B-cell proliferation characteristics and monitoring significance under the modified reduced-dose rituximab regimen for NMOSD: A real-world case series study
Author: Cao, Shugang; Wang, Xiaoyuan; Ji, Xiaopei; Tian, Jingluan; Zhu, Yunfei; Wang, Xin; Gu, Yanzheng; Duan, Xiaoyu; Xiao, Xinyi; Fang, Qi; Zhang, Xueguang; Xue, Qun

Journal: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2023; Vol. 70, Issue , pp. -. DOI: 10.1016/j.msard.2023.104524
7、Clinical characteristics of late-onset neuromyelitis optica spectrum disorder
Author: Min, Wanwan; Zhang, Li; Wang, Shengnan; Xue, Mengru; Guo, Chunjie; Zhu, Mingqin

Journal: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2023; Vol. 70, Issue , pp. -. DOI: 10.1016/j.msard.2023.104517
8、Microstructural alterations in different types of lesions and their perilesional white matter in relapsing-remitting multiple sclerosis based on diffusion kurtosis imaging
Author: Shi, Zhuowei; Pan, Yang; Yan, Zichun; Ding, Shuang; Hu, Hai; Wei, Yiqiu; Luo, Dan; Xu, Yuhui; Zhu, Qiyuan; Li, Yongmei

Journal: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2023; Vol. 71, Issue , pp. -. DOI: 10.1016/j.msard.2023.104572